Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first in class, proof-of-concept, single arm phase 2 study
Gespeichert in:
| Veröffentlicht in: | The lancet oncology 2018-01, Vol.19 (2), p.207-215 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 215 |
|---|---|
| container_issue | 2 |
| container_start_page | 207 |
| container_title | The lancet oncology |
| container_volume | 19 |
| creator | Lee, Jung-Min Nair, Jayakumar Zimmer, Alexandra Lipkowitz, Stanley Annunziata, Christina M. Merino, Maria J. Swisher, Elizabeth M. Harrell, Maria I. Trepel, Jane B. Lee, Min-Jung Bagheri, Mohammad H. Botesteanu, Dana-Adriana Steinberg, Seth M. Minasian, Lori Ekwede, Irene Kohn, Elise C. |
| description | |
| doi_str_mv | 10.1016/S1470-2045(18)30009-3 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7366122</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_7366122</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_73661223</originalsourceid><addsrcrecordid>eNqlTstOwzAQtBCIlscnIO0RpBjsJE1bDkhQgTgi4B65jpuYura1dgr5NP4OF7hwRlppRzuzM0PIGWeXnPHq6oWXU0ZzVk7O-eyiYIzNabFHxulc0kk5m-1_4x_JiByF8MYYn3I2OSSjfF5UO3JMPp9QfYigMOplBgKkMgbkII0C2Sm59k7bCGttkwY4CNtADtp2eqmjwyxBuHte3MK7Ng2Ng1eASvaIKn11uu1oi6JRkAJcH8BtBWphQQorFV6nvJXGEHcu0ogQMvDo3IqmkS5JfMwgaNumNgI34LtdixxC7JvhhByshAnq9Hcfk5uH-9fFI_X9cqMamRqgMLVHvRE41E7o-i9jdVe3bltPi6rieV782-ALKXSDlA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first in class, proof-of-concept, single arm phase 2 study</title><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Lee, Jung-Min ; Nair, Jayakumar ; Zimmer, Alexandra ; Lipkowitz, Stanley ; Annunziata, Christina M. ; Merino, Maria J. ; Swisher, Elizabeth M. ; Harrell, Maria I. ; Trepel, Jane B. ; Lee, Min-Jung ; Bagheri, Mohammad H. ; Botesteanu, Dana-Adriana ; Steinberg, Seth M. ; Minasian, Lori ; Ekwede, Irene ; Kohn, Elise C.</creator><creatorcontrib>Lee, Jung-Min ; Nair, Jayakumar ; Zimmer, Alexandra ; Lipkowitz, Stanley ; Annunziata, Christina M. ; Merino, Maria J. ; Swisher, Elizabeth M. ; Harrell, Maria I. ; Trepel, Jane B. ; Lee, Min-Jung ; Bagheri, Mohammad H. ; Botesteanu, Dana-Adriana ; Steinberg, Seth M. ; Minasian, Lori ; Ekwede, Irene ; Kohn, Elise C.</creatorcontrib><identifier>ISSN: 1470-2045</identifier><identifier>EISSN: 1474-5488</identifier><identifier>DOI: 10.1016/S1470-2045(18)30009-3</identifier><identifier>PMID: 29361470</identifier><language>eng</language><ispartof>The lancet oncology, 2018-01, Vol.19 (2), p.207-215</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids></links><search><creatorcontrib>Lee, Jung-Min</creatorcontrib><creatorcontrib>Nair, Jayakumar</creatorcontrib><creatorcontrib>Zimmer, Alexandra</creatorcontrib><creatorcontrib>Lipkowitz, Stanley</creatorcontrib><creatorcontrib>Annunziata, Christina M.</creatorcontrib><creatorcontrib>Merino, Maria J.</creatorcontrib><creatorcontrib>Swisher, Elizabeth M.</creatorcontrib><creatorcontrib>Harrell, Maria I.</creatorcontrib><creatorcontrib>Trepel, Jane B.</creatorcontrib><creatorcontrib>Lee, Min-Jung</creatorcontrib><creatorcontrib>Bagheri, Mohammad H.</creatorcontrib><creatorcontrib>Botesteanu, Dana-Adriana</creatorcontrib><creatorcontrib>Steinberg, Seth M.</creatorcontrib><creatorcontrib>Minasian, Lori</creatorcontrib><creatorcontrib>Ekwede, Irene</creatorcontrib><creatorcontrib>Kohn, Elise C.</creatorcontrib><title>Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first in class, proof-of-concept, single arm phase 2 study</title><title>The lancet oncology</title><issn>1470-2045</issn><issn>1474-5488</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqlTstOwzAQtBCIlscnIO0RpBjsJE1bDkhQgTgi4B65jpuYura1dgr5NP4OF7hwRlppRzuzM0PIGWeXnPHq6oWXU0ZzVk7O-eyiYIzNabFHxulc0kk5m-1_4x_JiByF8MYYn3I2OSSjfF5UO3JMPp9QfYigMOplBgKkMgbkII0C2Sm59k7bCGttkwY4CNtADtp2eqmjwyxBuHte3MK7Ng2Ng1eASvaIKn11uu1oi6JRkAJcH8BtBWphQQorFV6nvJXGEHcu0ogQMvDo3IqmkS5JfMwgaNumNgI34LtdixxC7JvhhByshAnq9Hcfk5uH-9fFI_X9cqMamRqgMLVHvRE41E7o-i9jdVe3bltPi6rieV782-ALKXSDlA</recordid><startdate>20180118</startdate><enddate>20180118</enddate><creator>Lee, Jung-Min</creator><creator>Nair, Jayakumar</creator><creator>Zimmer, Alexandra</creator><creator>Lipkowitz, Stanley</creator><creator>Annunziata, Christina M.</creator><creator>Merino, Maria J.</creator><creator>Swisher, Elizabeth M.</creator><creator>Harrell, Maria I.</creator><creator>Trepel, Jane B.</creator><creator>Lee, Min-Jung</creator><creator>Bagheri, Mohammad H.</creator><creator>Botesteanu, Dana-Adriana</creator><creator>Steinberg, Seth M.</creator><creator>Minasian, Lori</creator><creator>Ekwede, Irene</creator><creator>Kohn, Elise C.</creator><scope>5PM</scope></search><sort><creationdate>20180118</creationdate><title>Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first in class, proof-of-concept, single arm phase 2 study</title><author>Lee, Jung-Min ; Nair, Jayakumar ; Zimmer, Alexandra ; Lipkowitz, Stanley ; Annunziata, Christina M. ; Merino, Maria J. ; Swisher, Elizabeth M. ; Harrell, Maria I. ; Trepel, Jane B. ; Lee, Min-Jung ; Bagheri, Mohammad H. ; Botesteanu, Dana-Adriana ; Steinberg, Seth M. ; Minasian, Lori ; Ekwede, Irene ; Kohn, Elise C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_73661223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Jung-Min</creatorcontrib><creatorcontrib>Nair, Jayakumar</creatorcontrib><creatorcontrib>Zimmer, Alexandra</creatorcontrib><creatorcontrib>Lipkowitz, Stanley</creatorcontrib><creatorcontrib>Annunziata, Christina M.</creatorcontrib><creatorcontrib>Merino, Maria J.</creatorcontrib><creatorcontrib>Swisher, Elizabeth M.</creatorcontrib><creatorcontrib>Harrell, Maria I.</creatorcontrib><creatorcontrib>Trepel, Jane B.</creatorcontrib><creatorcontrib>Lee, Min-Jung</creatorcontrib><creatorcontrib>Bagheri, Mohammad H.</creatorcontrib><creatorcontrib>Botesteanu, Dana-Adriana</creatorcontrib><creatorcontrib>Steinberg, Seth M.</creatorcontrib><creatorcontrib>Minasian, Lori</creatorcontrib><creatorcontrib>Ekwede, Irene</creatorcontrib><creatorcontrib>Kohn, Elise C.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>The lancet oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Jung-Min</au><au>Nair, Jayakumar</au><au>Zimmer, Alexandra</au><au>Lipkowitz, Stanley</au><au>Annunziata, Christina M.</au><au>Merino, Maria J.</au><au>Swisher, Elizabeth M.</au><au>Harrell, Maria I.</au><au>Trepel, Jane B.</au><au>Lee, Min-Jung</au><au>Bagheri, Mohammad H.</au><au>Botesteanu, Dana-Adriana</au><au>Steinberg, Seth M.</au><au>Minasian, Lori</au><au>Ekwede, Irene</au><au>Kohn, Elise C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first in class, proof-of-concept, single arm phase 2 study</atitle><jtitle>The lancet oncology</jtitle><date>2018-01-18</date><risdate>2018</risdate><volume>19</volume><issue>2</issue><spage>207</spage><epage>215</epage><pages>207-215</pages><issn>1470-2045</issn><eissn>1474-5488</eissn><pmid>29361470</pmid><doi>10.1016/S1470-2045(18)30009-3</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1470-2045 |
| ispartof | The lancet oncology, 2018-01, Vol.19 (2), p.207-215 |
| issn | 1470-2045 1474-5488 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7366122 |
| source | ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
| title | Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first in class, proof-of-concept, single arm phase 2 study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A14%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prexasertib,%20a%20cell%20cycle%20checkpoint%20kinase%201%20and%202%20inhibitor,%20in%20BRCA%20wild-type%20recurrent%20high-grade%20serous%20ovarian%20cancer:%20a%20first%20in%20class,%20proof-of-concept,%20single%20arm%20phase%202%20study&rft.jtitle=The%20lancet%20oncology&rft.au=Lee,%20Jung-Min&rft.date=2018-01-18&rft.volume=19&rft.issue=2&rft.spage=207&rft.epage=215&rft.pages=207-215&rft.issn=1470-2045&rft.eissn=1474-5488&rft_id=info:doi/10.1016/S1470-2045(18)30009-3&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_7366122%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/29361470&rfr_iscdi=true |